Member Info for bakky

It would be helpful if Mr Little can firstly come up with a good antibody test, then maybe a vaccine in 6 months time..lol

currently there is no antibody test that is any good. They have tested them and some are so bad that they only pick up 25% of positive results. Ncyt (antigen) test will be around for a while yet.

Atisha, he didn't say 'the first 3 suppliers test had failed'. He said ONE supplier had 3 out of four tests fail, so only had a 25% success rate.That is how I thought it was anyway.

good summary there flipper, cheers!

There ya go, already had one in the last Y/E lol.

Current Trading & Outlook

The momentum experienced in Q4 has continued into the first quarter with healthy trading being experienced across all regions through the channel in Q1 2020 with no initial signs of automated sales through the channel from any region (notably China) being negatively impacted by coronavirus to date. That said, working practices are having to be significantly adjusted as a result of key industry events being cancelled, international travel being temporarily curtailed, and our office based staff having to work remotely.

Any immediate impact is therefore likely to be most noticeable in our one-off brokered sales, which currently account for less than 10% of our business, and certain aspects of business development. Longer term, the extent to which the wider environment may impact us is an unknown. However, the high levels of our recurring revenues and online nature of the majority of our sales should, in theory, shield us from the worst of the immediate storm. But to believe that we are fully insulated from the global crisis would be unwise.

For clarity it won't affect NIPT production as below states;

'Should the requirement to produce COVID-19 tests expand, the Company may need to increase capacity to replenish PCR stocks and maintain continuity of supply of existing Yourgene product lines. The Company is well prepared to do this and is able to utilise its expertise in automation to assist in the scale up of production'.

Simon. I wouldn't worry at all .There is plenty for everyone. Ygen will be very busy both with NHS testing and work for NCYT. The 'big' pharmas coming in will not take any work away from Ygen, who will be flat out, as they all will be. There is more than enough to go around. I would think your investment here is safer than most at this present time. There are a few good news rns's to come here in the near term, and don't forget the CE approval is imminent too.

it's not just profit taking, I think it is also capital gains motivated. Should clear this week as new year starts next week.

'British Federal' as in the welding machine company? We used to buy our welders from them! Small world eh?

ha ha! he won't even buy shares in the company he runs so 'successfully',... even at these low prices.

probably a lot of capital gains trades going on just now. It will soon end, then hopefully we'll be away.

exactly right norrab! but don't hold yer breath! At first I thought and hoped this management were a little different to other small aim bosses, I was wrong.Certainly not slouches when it comes to their own rewards are they?

https://ukinvestormagazine.co.uk/yourgene-to-assist-with-covid-19-testing/

hxxps://ukinvestormagazine.co.uk/yourgene-to-assist-with-covid-19-testing/

that big sell is from yesterday

About as useful as a chocolate teapot! Basically says it picks up any old virus and positive or negative results are not to be trusted ffs! Also needs trained (experts) to use the thing, jeeez!

'Positive results are
indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other
diagnostic information is necessary to determine patient infection status. Positive results do not
rule out bacterial infection or co-infection with other viruses. Testing facilities within the United
States and its territories are required to report all positive results to the appropriate public health
authorities.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis
for patient management decisions. Negative results must be combined with clinical observations,
patient history, and epidemiological information.
The ID NOW COVID-19 test is intended for use by medical professionals or trained operators who
are proficient in performing tests using the ID NOW Instrument. The ID NOW COVID-19 test is
only for use under the Food and Drug Administration’s Emergency Use Authorization'

perhaps Mr Peston can find out why they say NCYT is not upto scratch in quality and delivery?? That's news to me!!

isn't NCYT the the 'gold standard' best out there?? So why are they reporting the opposite?

'Last night the Department of Health suggested the tests provided by Novacyt were not as efficient as those being offered by other companies'.
also,
'But last night a Public Health England (PHE) spokesman claimed Novacyt was not providing more tests because it was ‘not able to offer the guaranteed continuity of supply we were looking for’
What's that all about??

a share buyback in operation, hmmm! Has anyone told FinCRAP yet?? They have previously bought at an average of 5.99p.So WTF don't they buy now at lower levels?